MedTrace Logo

Intima Media Thickness Regression in Dyslipidemic Teenagers

NCT01768481 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2013-01-15

No results posted yet for this study

Summary

Randomized controlled trial of statin intervention in dyslipidemic obese teenagers. Primary outcome is intima media thickness before and after intervention.

Conditions

Interventions

DRUG

Atorvastatin

10 mg Atorvastatin vs placebo daily in a randomized controlled trial for one year

DRUG

sugar pill

placebo controlled arm receives similarly looking placebo.

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Université de Montréal

    lead OTHER

Principal Investigators

  • Laurent Legault, MD · Hopital Maisonneuve-Rosemont, UMontreal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2009-12-31
Completion
2010-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01768481 on ClinicalTrials.gov